===== phenotype 5=================================================================
proportion of pts: 0.11106703689
lambda: 7973.95045904
----------------------------------------
Ischemic heart disease	0.204
Other forms of heart disease	0.177
Hypertensive disease	0.171
Disorders of lipoid metabolism	0.169
Range name na	0.142
Symptoms involving respiratory system and other chest symptoms	0.137
----------------------------------------
Adrenergic beta-1 Receptor Antagonists	0.122
Platelet Aggregation Inhibitors	0.115
Fibrinolytic Agents	0.114
Sympatholytics	0.114
Anti-Arrhythmia Agents	0.113
Diuretics	0.111
Antipyretics	0.106
Anti-Inflammatory Agents, Non-Steroidal	0.104
Cyclooxygenase Inhibitors	0.101
===== phenotype 47=================================================================
proportion of pts: 0.122570408568
lambda: 7685.35366938
----------------------------------------
Disorders of lipoid metabolism	0.185
Hypertensive disease	0.183
Arthropathies and related disorders	0.157
Acute respiratory infections	0.145
Diabetes	0.113
Symptoms involving respiratory system and other chest symptoms	0.111
Rheumatism, excluding the back	0.106
----------------------------------------
Antipyretics	0.133
Fibrinolytic Agents	0.130
Anti-Inflammatory Agents, Non-Steroidal	0.129
Cyclooxygenase Inhibitors	0.129
Platelet Aggregation Inhibitors	0.126
Antihypertensive Agents	0.120
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.119
Anticholesteremic Agents	0.114
===== phenotype 13=================================================================
proportion of pts: 0.130503768346
lambda: 7683.02909307
----------------------------------------
Diabetes	0.259
Disorders of lipoid metabolism	0.192
Hypertensive disease	0.192
Ischemic heart disease	0.134
Range name na	0.117
Disorders of the eye and adnexa	0.106
----------------------------------------
Hypoglycemic Agents	0.156
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.126
Anticholesteremic Agents	0.125
Platelet Aggregation Inhibitors	0.122
Fibrinolytic Agents	0.120
Anti-Arrhythmia Agents	0.119
Anti-Inflammatory Agents, Non-Steroidal	0.116
Cyclooxygenase Inhibitors	0.115
===== phenotype 0=================================================================
proportion of pts: 0.113447044823
lambda: 7670.23229325
----------------------------------------
Disorders of lipoid metabolism	0.161
Hypertensive disease	0.158
Other diseases of urinary system	0.154
General symptoms	0.146
Symptoms involving urinary system	0.140
Range name na	0.122
Arthropathies and related disorders	0.118
----------------------------------------
Fibrinolytic Agents	0.121
Platelet Aggregation Inhibitors	0.119
Antipyretics	0.114
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.112
Anticholesteremic Agents	0.112
Anti-Inflammatory Agents, Non-Steroidal	0.109
Cyclooxygenase Inhibitors	0.107
Antihypertensive Agents	0.104
Hypolipidemic Agents	0.102
===== phenotype 22=================================================================
proportion of pts: 0.115033716779
lambda: 6998.85220191
----------------------------------------
Other diseases of the upper respiratory tract	0.182
Hypertensive disease	0.171
Acute respiratory infections	0.158
Symptoms involving respiratory system and other chest symptoms	0.153
Disorders of lipoid metabolism	0.120
Chronic obstructive pulmonary disease and allied conditions	0.115
Disorders of the eye and adnexa	0.102
----------------------------------------
Anti-Allergic Agents	0.146
Anti-Inflammatory Agents	0.142
Bronchodilator Agents	0.138
Histamine H1 Antagonists, Non-Sedating	0.122
Antihypertensive Agents	0.118
Dermatologic Agents	0.117
Anti-Bacterial Agents	0.109
Glucocorticoids	0.109
===== phenotype 34=================================================================
proportion of pts: 0.109083696946
lambda: 6946.78944037
----------------------------------------
Hypertensive disease	0.147
Range name na	0.137
Rheumatism, excluding the back	0.131
Diabetes	0.128
Disorders of lipoid metabolism	0.120
Other forms of heart disease	0.113
Disorders of the eye and adnexa	0.112
Arthropathies and related disorders	0.112
----------------------------------------
Diuretics	0.170
Vasodilator Agents	0.160
Calcium Channel Blockers	0.148
Sodium Potassium Chloride Symporter Inhibitors	0.139
Anti-Arrhythmia Agents	0.137
Sympatholytics	0.125
Antihypertensive Agents	0.121
===== phenotype 9=================================================================
proportion of pts: 0.111463704879
lambda: 6740.18168711
----------------------------------------
Diabetes	0.235
Hypertensive disease	0.178
Disorders of lipoid metabolism	0.176
Rheumatism, excluding the back	0.150
Disorders of the eye and adnexa	0.145
Organic sleep disorders	0.115
----------------------------------------
Hypoglycemic Agents	0.124
Antipyretics	0.115
Anti-Inflammatory Agents, Non-Steroidal	0.112
Platelet Aggregation Inhibitors	0.111
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.110
Fibrinolytic Agents	0.110
Cyclooxygenase Inhibitors	0.109
Anticholesteremic Agents	0.105
Hypolipidemic Agents	0.104
===== phenotype 25=================================================================
proportion of pts: 0.113447044823
lambda: 6438.19047465
----------------------------------------
Dorsopathies	0.182
Arthropathies and related disorders	0.167
Hypertensive disease	0.151
Rheumatism, excluding the back	0.148
Range name na	0.136
Disorders of lipoid metabolism	0.109
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.108
----------------------------------------
Anti-Inflammatory Agents	0.140
Anti-Allergic Agents	0.137
Calcium Channel Blockers	0.132
Antihypertensive Agents	0.127
Glucocorticoids	0.126
Anti-Inflammatory Agents, Non-Steroidal	0.116
Dermatologic Agents	0.111
Cyclooxygenase Inhibitors	0.111
===== phenotype 2=================================================================
proportion of pts: 0.108290360968
lambda: 6407.08165184
----------------------------------------
Hypertensive disease	0.182
Disorders of lipoid metabolism	0.165
Other forms of heart disease	0.162
Symptoms involving respiratory system and other chest symptoms	0.132
Range name na	0.131
Symptoms involving skin and other integumentary tissue	0.120
Symptoms involving cardiovascular system	0.107
----------------------------------------
Vasodilator Agents	0.135
Anti-Inflammatory Agents, Non-Steroidal	0.127
Fibrinolytic Agents	0.125
Platelet Aggregation Inhibitors	0.125
Antihypertensive Agents	0.124
Antipyretics	0.124
Cyclooxygenase Inhibitors	0.121
Anti-Arrhythmia Agents	0.119
===== phenotype 39=================================================================
proportion of pts: 0.117017056724
lambda: 6310.90891531
----------------------------------------
Hypertensive disease	0.184
Nutritional deficiencies	0.180
Range name na	0.153
Disorders of lipoid metabolism	0.130
Arthropathies and related disorders	0.128
Disorders of the eye and adnexa	0.118
General symptoms	0.107
----------------------------------------
Bone Density Conservation Agents	0.154
Vitamins	0.154
Vitamin B Complex	0.131
Antioxidants	0.123
Antihypertensive Agents	0.123
Antipyretics	0.110
Anti-Inflammatory Agents, Non-Steroidal	0.104
Cyclooxygenase Inhibitors	0.100
===== phenotype 44=================================================================
proportion of pts: 0.103133677112
lambda: 5997.55872449
----------------------------------------
Hypertensive disease	0.157
Disorders of lipoid metabolism	0.143
Range name na	0.123
Disorders of the eye and adnexa	0.123
Other diseases of skin and subcutaneous tissue	0.120
Arthropathies and related disorders	0.118
Ischemic heart disease	0.114
Mycoses	0.103
----------------------------------------
Antihypertensive Agents	0.144
Angiotensin-Converting Enzyme Inhibitors	0.141
Anticholesteremic Agents	0.128
Cardiotonic Agents	0.125
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.122
Diuretics	0.116
Anti-Ulcer Agents	0.115
Proton Pump Inhibitors	0.110
===== phenotype 21=================================================================
proportion of pts: 0.0999603332011
lambda: 5888.45106378
----------------------------------------
Arthropathies and related disorders	0.159
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.153
Hypertensive disease	0.152
Range name na	0.136
Rheumatism, excluding the back	0.136
Dorsopathies	0.134
General symptoms	0.130
----------------------------------------
Calcium Channel Blockers	0.143
Anti-Arrhythmia Agents	0.134
Analgesics	0.130
Anti-Ulcer Agents	0.127
Anticonvulsants	0.122
Anti-Anxiety Agents	0.120
Antipyretics	0.112
Serotonin Uptake Inhibitors	0.111
===== phenotype 42=================================================================
proportion of pts: 0.101547005157
lambda: 5413.2257731
----------------------------------------
Hypertensive disease	0.188
General symptoms	0.162
Range name na	0.136
Disorders of lipoid metabolism	0.134
Symptoms involving respiratory system and other chest symptoms	0.133
Arthropathies and related disorders	0.129
Rheumatism, excluding the back	0.117
----------------------------------------
Hypnotics and Sedatives	0.164
Anticonvulsants	0.158
Antiemetics	0.156
GABA Modulators	0.151
Anti-Anxiety Agents	0.148
Histamine H1 Antagonists	0.113
Serotonin Uptake Inhibitors	0.110
===== phenotype 11=================================================================
proportion of pts: 0.109480364935
lambda: 5255.13798707
----------------------------------------
Hypertensive disease	0.179
Range name na	0.177
Arthropathies and related disorders	0.143
Rheumatism, excluding the back	0.142
General symptoms	0.126
Disorders of lipoid metabolism	0.121
Symptoms involving respiratory system and other chest symptoms	0.111
----------------------------------------
Analgesics, Opioid	0.157
Narcotics	0.149
Antirheumatic Agents	0.127
Immunosuppressive Agents	0.119
Antimalarials	0.119
Anti-Infective Agents, Urinary	0.115
Enzyme Inhibitors	0.113
Antifungal Agents	0.101
===== phenotype 24=================================================================
proportion of pts: 0.0833002776676
lambda: 5064.20121216
----------------------------------------
Hypertensive disease	0.201
Range name na	0.167
Disorders of lipoid metabolism	0.146
Arthropathies and related disorders	0.141
Symptoms involving respiratory system and other chest symptoms	0.124
Rheumatism, excluding the back	0.111
General symptoms	0.109
----------------------------------------
Adrenergic beta-1 Receptor Antagonists	0.135
Sympatholytics	0.121
Enzyme Inhibitors	0.113
Folic Acid Antagonists	0.112
Nucleic Acid Synthesis Inhibitors	0.107
Immunosuppressive Agents	0.104
Dermatologic Agents	0.104
Abortifacient Agents, Nonsteroidal	0.103
Antimetabolites, Antineoplastic	0.102
===== phenotype 45=================================================================
proportion of pts: 0.0924236414121
lambda: 5046.28497604
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.147
Hypertensive disease	0.147
Disorders of lipoid metabolism	0.138
General symptoms	0.125
Range name na	0.116
Diseases of esophagus, stomach, and duodenum	0.114
Neoplasm of uncertain behavior of other sites & tissues	0.108
Symptoms involving respiratory system and other chest symptoms	0.104
----------------------------------------
Anti-Ulcer Agents	0.139
Anti-Allergic Agents	0.138
Proton Pump Inhibitors	0.135
Antihypertensive Agents	0.127
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.118
Anticholesteremic Agents	0.117
Anti-Inflammatory Agents	0.115
Bronchodilator Agents	0.110
===== phenotype 20=================================================================
proportion of pts: 0.10392701309
lambda: 4983.37267003
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.199
Arthropathies and related disorders	0.128
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.120
Dorsopathies	0.117
Rheumatism, excluding the back	0.109
Symptoms involving skin and other integumentary tissue	0.109
Malignant neoplasm of skin	0.109
Neoplasm of uncertain behavior of other sites & tissues	0.108
----------------------------------------
Platelet Aggregation Inhibitors	0.175
Antipyretics	0.175
Fibrinolytic Agents	0.173
Anti-Inflammatory Agents, Non-Steroidal	0.163
Cyclooxygenase Inhibitors	0.161
Antihypertensive Agents	0.153
===== phenotype 12=================================================================
proportion of pts: 0.0920269734232
lambda: 4970.67679151
----------------------------------------
Range name na	0.172
Other forms of heart disease	0.168
Hypertensive disease	0.157
Disorders of lipoid metabolism	0.148
Symptoms involving respiratory system and other chest symptoms	0.123
Ischemic heart disease	0.120
Arthropathies and related disorders	0.113
----------------------------------------
Anticoagulants	0.154
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.149
Rodenticides	0.143
Anticholesteremic Agents	0.142
Hypolipidemic Agents	0.141
Anti-Arrhythmia Agents	0.139
Sympatholytics	0.133
===== phenotype 28=================================================================
proportion of pts: 0.0900436334788
lambda: 4806.5717819
----------------------------------------
Disorders of lipoid metabolism	0.203
Hypertensive disease	0.185
Ischemic heart disease	0.179
Symptoms involving respiratory system and other chest symptoms	0.177
Other diseases of skin and subcutaneous tissue	0.132
Chronic obstructive pulmonary disease and allied conditions	0.124
----------------------------------------
Vasodilator Agents	0.136
Platelet Aggregation Inhibitors	0.131
Anticholesteremic Agents	0.129
Fibrinolytic Agents	0.128
Hypolipidemic Agents	0.128
Anti-Inflammatory Agents, Non-Steroidal	0.117
Cyclooxygenase Inhibitors	0.116
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.115
===== phenotype 16=================================================================
proportion of pts: 0.0884569615232
lambda: 4759.34584024
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.166
Chronic obstructive pulmonary disease and allied conditions	0.165
Disorders of lipoid metabolism	0.141
Hypertensive disease	0.141
Diabetes	0.141
Ischemic heart disease	0.128
Range name na	0.118
----------------------------------------
Tocolytic Agents	0.168
Bronchodilator Agents	0.156
Adrenergic beta-2 Receptor Agonists	0.149
Vasodilator Agents	0.144
Antihypertensive Agents	0.138
Antipyretics	0.133
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.112
===== phenotype 48=================================================================
proportion of pts: 0.0999603332011
lambda: 4557.30076601
----------------------------------------
Diseases of esophagus, stomach, and duodenum	0.189
Hypertensive disease	0.168
Symptoms involving respiratory system and other chest symptoms	0.140
Arthropathies and related disorders	0.138
Disorders of lipoid metabolism	0.136
General symptoms	0.117
Rheumatism, excluding the back	0.112
----------------------------------------
Proton Pump Inhibitors	0.189
Anti-Ulcer Agents	0.186
Anti-Inflammatory Agents, Non-Steroidal	0.159
Cyclooxygenase Inhibitors	0.157
Vitamins	0.155
Platelet Aggregation Inhibitors	0.154
===== phenotype 8=================================================================
proportion of pts: 0.0908369694566
lambda: 4494.13616819
----------------------------------------
Hypertensive disease	0.148
Symptoms involving respiratory system and other chest symptoms	0.145
Disorders of lipoid metabolism	0.137
Diseases of esophagus, stomach, and duodenum	0.126
Range name na	0.125
Diabetes	0.114
Ischemic heart disease	0.106
General symptoms	0.101
----------------------------------------
Anti-Ulcer Agents	0.207
Proton Pump Inhibitors	0.205
Hypnotics and Sedatives	0.173
Anti-Anxiety Agents	0.147
Antipyretics	0.139
GABA Modulators	0.129
===== phenotype 31=================================================================
proportion of pts: 0.0920269734232
lambda: 4433.03831599
----------------------------------------
Diseases of arteries, arterioles, and capillaries	0.139
Other forms of heart disease	0.138
Hypertensive disease	0.136
Diseases of male genital organs	0.122
Other symptoms involving abdomen and pelvis	0.119
Other diseases of urinary system	0.119
Symptoms involving cardiovascular system	0.116
Other diseases of intestines and peritoneum	0.111
----------------------------------------
Anticholesteremic Agents	0.131
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.130
Antihypertensive Agents	0.127
Platelet Aggregation Inhibitors	0.126
Antipyretics	0.124
Vasodilator Agents	0.122
Fibrinolytic Agents	0.122
Cyclooxygenase Inhibitors	0.118
===== phenotype 37=================================================================
proportion of pts: 0.108687028957
lambda: 4228.23287641
----------------------------------------
Na	0.200
Hypertensive disease	0.165
Rheumatism, excluding the back	0.134
Disorders of lipoid metabolism	0.132
Symptoms involving respiratory system and other chest symptoms	0.131
Neurotic, personality, nonpsychotic disorders	0.130
Drug dependence	0.107
----------------------------------------
Antidepressive Agents, Second-Generation	0.203
Serotonin Uptake Inhibitors	0.186
Antipyretics	0.165
Antihypertensive Agents	0.158
Anti-Inflammatory Agents, Non-Steroidal	0.145
Cyclooxygenase Inhibitors	0.143
===== phenotype 38=================================================================
proportion of pts: 0.0999603332011
lambda: 4196.01453641
----------------------------------------
Disorders of the peripheral nervous system	0.191
Diabetes	0.164
Disorders of lipoid metabolism	0.139
Hypertensive disease	0.139
Nephritis, nephrotic syndrome, and nephrosis	0.125
Rheumatism, excluding the back	0.124
Arthropathies and related disorders	0.118
----------------------------------------
Hypoglycemic Agents	0.189
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.172
Anticholesteremic Agents	0.171
Antihypertensive Agents	0.169
Analgesics	0.152
Anticonvulsants	0.147
===== phenotype 49=================================================================
proportion of pts: 0.0975803252678
lambda: 4189.6388611
----------------------------------------
Other forms of heart disease	0.171
Hypertensive disease	0.157
Range name na	0.147
General symptoms	0.142
Symptoms involving skin and other integumentary tissue	0.137
Symptoms involving respiratory system and other chest symptoms	0.126
Arthropathies and related disorders	0.120
----------------------------------------
Diuretics	0.201
Anti-Inflammatory Agents	0.185
Anti-Allergic Agents	0.174
Sodium Potassium Chloride Symporter Inhibitors	0.158
Antihypertensive Agents	0.142
Bronchodilator Agents	0.141
===== phenotype 17=================================================================
proportion of pts: 0.0868702895676
lambda: 4141.67364123
----------------------------------------
Hypertensive disease	0.201
Disorders of lipoid metabolism	0.177
Range name na	0.173
Gout	0.160
Ischemic heart disease	0.151
Other forms of heart disease	0.139
----------------------------------------
Gout Suppressants	0.145
Vasodilator Agents	0.137
Enzyme Inhibitors	0.127
Antipyretics	0.126
Antimetabolites	0.124
Anti-Inflammatory Agents, Non-Steroidal	0.118
Cyclooxygenase Inhibitors	0.113
Adrenergic alpha-1 Receptor Antagonists	0.111
===== phenotype 46=================================================================
proportion of pts: 0.117413724712
lambda: 4122.55497564
----------------------------------------
Disorders of thyroid gland	0.236
Hypertensive disease	0.236
Disorders of lipoid metabolism	0.226
Organic sleep disorders	0.154
Symptoms involving respiratory system and other chest symptoms	0.148
----------------------------------------
Diuretics	0.161
Antihypertensive Agents	0.159
Anti-Arrhythmia Agents	0.148
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.139
Anticholesteremic Agents	0.134
Calcium Channel Blockers	0.131
Sodium Chloride Symporter Inhibitors	0.129
===== phenotype 7=================================================================
proportion of pts: 0.0829036096787
lambda: 3970.05787169
----------------------------------------
Range name na	0.180
Hypertensive disease	0.180
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.146
Disorders of lipoid metabolism	0.144
Disorders of thyroid gland	0.127
General symptoms	0.118
Malignant neoplasm of breast	0.105
----------------------------------------
Vitamins	0.143
Bone Density Conservation Agents	0.140
Antihypertensive Agents	0.127
Angiotensin-Converting Enzyme Inhibitors	0.124
Antipyretics	0.120
Anti-Inflammatory Agents, Non-Steroidal	0.116
Fibrinolytic Agents	0.116
Cyclooxygenase Inhibitors	0.115
===== phenotype 43=================================================================
proportion of pts: 0.0852836176121
lambda: 3831.62195171
----------------------------------------
General symptoms	0.188
Disorders of the eye and adnexa	0.186
Range name na	0.179
Acute respiratory infections	0.157
Hypertensive disease	0.148
Symptoms involving respiratory system and other chest symptoms	0.142
----------------------------------------
Anti-Inflammatory Agents, Non-Steroidal	0.131
Antihypertensive Agents	0.130
Cyclooxygenase Inhibitors	0.130
Antipyretics	0.127
Platelet Aggregation Inhibitors	0.124
Fibrinolytic Agents	0.122
Vasodilator Agents	0.122
Anti-Inflammatory Agents	0.114
===== phenotype 32=================================================================
proportion of pts: 0.0868702895676
lambda: 3822.16190385
----------------------------------------
Hypertensive disease	0.149
Rheumatism, excluding the back	0.143
Arthropathies and related disorders	0.142
Dorsopathies	0.124
Symptoms involving respiratory system and other chest symptoms	0.114
Disorders of lipoid metabolism	0.113
Sprains and strains of joints and adjacent muscles	0.108
Range name na	0.108
----------------------------------------
Anti-Arrhythmia Agents	0.173
Vasodilator Agents	0.160
Antihypertensive Agents	0.144
Anesthetics, Local	0.136
Anti-Inflammatory Agents, Non-Steroidal	0.132
Cyclooxygenase Inhibitors	0.129
Anti-Inflammatory Agents	0.126
===== phenotype 40=================================================================
proportion of pts: 0.0662435541452
lambda: 3807.69387997
----------------------------------------
Miscellaneous diagnostic and therapeutic procedures	0.258
Operations on the cardiovascular system	0.196
Other diseases of respiratory system	0.191
Diseases of veins and lymphatics, and other diseases of circulatory system	0.134
Diseases of arteries, arterioles, and capillaries	0.111
Operations on the musculoskeletal system	0.110
----------------------------------------
Antihypertensive Agents	0.137
Antipyretics	0.137
Anti-Inflammatory Agents, Non-Steroidal	0.131
Cyclooxygenase Inhibitors	0.125
Fibrinolytic Agents	0.121
Platelet Aggregation Inhibitors	0.120
Anti-Arrhythmia Agents	0.120
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.109
===== phenotype 3=================================================================
proportion of pts: 0.09678698929
lambda: 3483.79260475
----------------------------------------
Other diseases of intestines and peritoneum	0.238
Symptoms involving digestive system	0.183
Hypertensive disease	0.159
Range name na	0.148
Other symptoms involving abdomen and pelvis	0.145
Diseases of esophagus, stomach, and duodenum	0.127
----------------------------------------
Antihypertensive Agents	0.156
Analgesics, Opioid	0.156
Narcotics	0.149
Antipyretics	0.141
Anti-Inflammatory Agents, Non-Steroidal	0.139
Hypnotics and Sedatives	0.133
Anti-Anxiety Agents	0.126
===== phenotype 29=================================================================
proportion of pts: 0.0852836176121
lambda: 3453.81491344
----------------------------------------
Symptoms involving digestive system	0.197
Other symptoms involving abdomen and pelvis	0.187
Nonspecific findings on examination of blood	0.127
Anemias	0.126
Other diseases of urinary system	0.126
Dorsopathies	0.125
Liver	0.111
----------------------------------------
Antihypertensive Agents	0.157
Anti-Arrhythmia Agents	0.144
Anti-Ulcer Agents	0.143
Cyclooxygenase Inhibitors	0.140
Anti-Inflammatory Agents, Non-Steroidal	0.140
Antipyretics	0.138
Vasodilator Agents	0.137
===== phenotype 18=================================================================
proportion of pts: 0.085680285601
lambda: 3407.15941782
----------------------------------------
Hypertensive disease	0.194
Disorders of lipoid metabolism	0.157
Range name na	0.152
Disorders of the eye and adnexa	0.137
Diabetes	0.124
Rheumatism, excluding the back	0.119
Other diseases of skin and subcutaneous tissue	0.116
----------------------------------------
Anticonvulsants	0.181
Excitatory Amino Acid Antagonists	0.175
Antiparkinson Agents	0.171
Anti-Anxiety Agents	0.171
Analgesics	0.152
Serotonin Uptake Inhibitors	0.150
===== phenotype 35=================================================================
proportion of pts: 0.0868702895676
lambda: 3387.70192216
----------------------------------------
Hypertensive disease	0.179
Diseases of esophagus, stomach, and duodenum	0.170
Arthropathies and related disorders	0.141
Rheumatism, excluding the back	0.139
Range name na	0.128
Disorders of lipoid metabolism	0.124
Other diseases of urinary system	0.119
----------------------------------------
Proton Pump Inhibitors	0.190
Anti-Ulcer Agents	0.179
Anti-Allergic Agents	0.176
Anti-Inflammatory Agents	0.165
Bronchodilator Agents	0.163
Antihypertensive Agents	0.127
===== phenotype 36=================================================================
proportion of pts: 0.0884569615232
lambda: 3335.56373594
----------------------------------------
Range name na	0.158
Dorsopathies	0.157
Hypertensive disease	0.154
Other disorders of female genital tract	0.149
General symptoms	0.132
Rheumatism, excluding the back	0.125
Arthropathies and related disorders	0.125
----------------------------------------
Analgesics, Non-Narcotic	0.233
Antipyretics	0.165
Anti-Inflammatory Agents, Non-Steroidal	0.162
Cyclooxygenase Inhibitors	0.162
Antihypertensive Agents	0.150
Estrogens	0.128
===== phenotype 30=================================================================
proportion of pts: 0.0880602935343
lambda: 2902.7220891
----------------------------------------
Hypertensive disease	0.175
Other forms of heart disease	0.163
Symptoms involving respiratory system and other chest symptoms	0.155
Range name na	0.149
Disorders of lipoid metabolism	0.127
Disorders of the eye and adnexa	0.127
General symptoms	0.104
----------------------------------------
Enzyme Inhibitors	0.220
Immunosuppressive Agents	0.207
Dermatologic Agents	0.201
Antirheumatic Agents	0.192
Antimetabolites, Antineoplastic	0.179
===== phenotype 15=================================================================
proportion of pts: 0.0844902816343
lambda: 2714.89425435
----------------------------------------
Dorsopathies	0.155
Rheumatism, excluding the back	0.133
Range name na	0.132
Hypertensive disease	0.126
Symptoms involving urinary system	0.120
Arthropathies and related disorders	0.116
Disorders of lipoid metabolism	0.114
Organic sleep disorders	0.104
----------------------------------------
Anti-Allergic Agents	0.264
Bronchodilator Agents	0.257
Anti-Ulcer Agents	0.247
Anti-Inflammatory Agents	0.231
===== phenotype 19=================================================================
proportion of pts: 0.0714002380008
lambda: 2443.14668212
----------------------------------------
Hypertensive disease	0.219
Disorders of lipoid metabolism	0.172
Diabetes	0.167
Disorders of thyroid gland	0.156
Arthropathies and related disorders	0.147
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.140
----------------------------------------
Dermatologic Agents	0.189
Anti-Allergic Agents	0.177
Bronchodilator Agents	0.167
Anti-Inflammatory Agents	0.165
Enzyme Inhibitors	0.155
Immunosuppressive Agents	0.147
===== phenotype 14=================================================================
proportion of pts: 0.0833002776676
lambda: 2358.59280792
----------------------------------------
Hypertensive disease	0.188
Range name na	0.162
Symptoms involving urinary system	0.153
Other diseases of urinary system	0.145
Disorders of lipoid metabolism	0.137
Nephritis, nephrotic syndrome, and nephrosis	0.108
Anemias	0.107
----------------------------------------
Enzyme Inhibitors	0.219
Antihypertensive Agents	0.207
Dermatologic Agents	0.206
Immunosuppressive Agents	0.187
Antirheumatic Agents	0.181
===== phenotype 33=================================================================
proportion of pts: 0.0920269734232
lambda: 2294.86847358
----------------------------------------
General symptoms	0.168
Symptoms involving respiratory system and other chest symptoms	0.168
Hypertensive disease	0.164
Other diseases of urinary system	0.130
Pneumonia and influenza	0.126
Other diseases of respiratory system	0.126
Other forms of heart disease	0.119
----------------------------------------
Anti-Bacterial Agents	0.331
Anti-Allergic Agents	0.249
Antihypertensive Agents	0.213
Bronchodilator Agents	0.206
===== phenotype 6=================================================================
proportion of pts: 0.0753669178897
lambda: 2254.02522954
----------------------------------------
Hypertensive disease	0.139
Na	0.138
Other symptoms involving abdomen and pelvis	0.130
Range name na	0.129
Neurotic, personality, nonpsychotic disorders	0.121
General symptoms	0.120
Diseases of esophagus, stomach, and duodenum	0.119
Organic sleep disorders	0.105
----------------------------------------
Serotonin Uptake Inhibitors	0.279
Antidepressive Agents, Second-Generation	0.277
Antihypertensive Agents	0.224
Anti-Anxiety Agents	0.219
===== phenotype 1=================================================================
proportion of pts: 0.0936136453788
lambda: 2217.72819536
----------------------------------------
Hypertensive disease	0.199
Disorders of lipoid metabolism	0.185
Diabetes	0.171
Organic sleep disorders	0.154
Nonspecific findings on examination of blood	0.147
Disorders of the eye and adnexa	0.144
----------------------------------------
Calcium Channel Blockers	0.282
Vasodilator Agents	0.258
Antihypertensive Agents	0.236
Analgesics	0.224
===== phenotype 27=================================================================
proportion of pts: 0.101943673146
lambda: 1830.44385601
----------------------------------------
Hypertensive disease	0.246
Disorders of lipoid metabolism	0.193
Range name na	0.190
General symptoms	0.188
Symptoms involving respiratory system and other chest symptoms	0.184
----------------------------------------
Angiotensin-Converting Enzyme Inhibitors	0.354
Vitamins	0.324
Calcium Channel Blockers	0.322
===== phenotype 4=================================================================
proportion of pts: 0.0805236017453
lambda: 1088.05446238
----------------------------------------
Overweight, obesity and other hyperalimentation	0.172
Symptoms involving skin and other integumentary tissue	0.169
Dorsopathies	0.147
Hypertensive disease	0.130
Anemias	0.129
Diabetes	0.128
Acute respiratory infections	0.125
----------------------------------------
Calcium Channel Blockers	0.525
Antihypertensive Agents	0.475
===== phenotype 26=================================================================
proportion of pts: 0.0606902023007
lambda: 755.987756843
----------------------------------------
Hypertensive disease	0.168
Range name na	0.159
Symptoms involving respiratory system and other chest symptoms	0.130
Disorders of lipoid metabolism	0.118
Other forms of heart disease	0.110
Ischemic heart disease	0.108
Rheumatism, excluding the back	0.104
General symptoms	0.103
----------------------------------------
Surface-Active Agents	1.000
===== phenotype 10=================================================================
proportion of pts: 0.0686235620785
lambda: 615.904330236
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.151
Anemias	0.141
Other diseases of respiratory system	0.140
Other forms of heart disease	0.136
Disorders of fluid, electrolyte, and acid-base balance	0.114
Hypertensive disease	0.109
Range name na	0.107
Pain	0.102
----------------------------------------
Anti-Anxiety Agents	1.000
===== phenotype 41=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
===== phenotype 23=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
